Inside the Lemonaid Health Buy: Kyle Pretsch on Bambu Ventures’s Bold Play
Bambu Ventures's Kyle Pretsch dives into Lemonaid’s $10M buyout, down from 23andMe’s $400M price tag, and what’s next after Chrome Co.’s dramatic pivot.
WSJ’s Alexander Gladstone reveals the story behind First Brands’ sudden bankruptcy: hidden deals, corporate chaos, and a mystery that shook the auto world.
Motley Fool’s Bill Mann unpacks October 10th's market chaos, what triggered it, and where smart investors should look next. Don’t miss his expert insight!
Jesse Pickard, CEO of The Mind Company, shares how Elevate and Balance are redefining mental fitness with science-backed tools for brainpower and wellness.